Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 23889773)

1.

Amyloid precursor protein in human breast cancer: an androgen-induced gene associated with cell proliferation.

Takagi K, Ito S, Miyazaki T, Miki Y, Shibahara Y, Ishida T, Watanabe M, Inoue S, Sasano H, Suzuki T.

Cancer Sci. 2013 Nov;104(11):1532-8. doi: 10.1111/cas.12239. Epub 2013 Aug 26.

PMID:
23889773
2.

Krüppel-like factor 5 in human breast carcinoma: a potent prognostic factor induced by androgens.

Takagi K, Miki Y, Onodera Y, Nakamura Y, Ishida T, Watanabe M, Inoue S, Sasano H, Suzuki T.

Endocr Relat Cancer. 2012 Nov 6;19(6):741-50. doi: 10.1530/ERC-12-0017. Print 2012 Dec.

3.

Identification of androgen-responsive microRNAs and androgen-related genes in breast cancer.

Nakano K, Miki Y, Hata S, Ebata A, Takagi K, McNamara KM, Sakurai M, Masuda M, Hirakawa H, Ishida T, Suzuki T, Ohuchi N, Sasano H.

Anticancer Res. 2013 Nov;33(11):4811-9.

PMID:
24222117
5.

5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production.

Suzuki T, Miki Y, Moriya T, Akahira J, Ishida T, Hirakawa H, Yamaguchi Y, Hayashi S, Sasano H.

Int J Cancer. 2007 Jan 15;120(2):285-91.

PMID:
17066438
6.

Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions.

Suzuki T, Hayashi S, Miki Y, Nakamura Y, Moriya T, Sugawara A, Ishida T, Ohuchi N, Sasano H.

Endocr Relat Cancer. 2006 Mar;13(1):233-50.

7.

Nucleobindin 2 in human breast carcinoma as a potent prognostic factor.

Suzuki S, Takagi K, Miki Y, Onodera Y, Akahira J, Ebata A, Ishida T, Watanabe M, Sasano H, Suzuki T.

Cancer Sci. 2012 Jan;103(1):136-43. doi: 10.1111/j.1349-7006.2011.02119.x. Epub 2011 Nov 17.

PMID:
21988594
8.

Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth.

Takayama K, Tsutsumi S, Suzuki T, Horie-Inoue K, Ikeda K, Kaneshiro K, Fujimura T, Kumagai J, Urano T, Sakaki Y, Shirahige K, Sasano H, Takahashi S, Kitamura T, Ouchi Y, Aburatani H, Inoue S.

Cancer Res. 2009 Jan 1;69(1):137-42. doi: 10.1158/0008-5472.CAN-08-3633.

9.

MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression.

Hall RE, Birrell SN, Tilley WD, Sutherland RL.

Eur J Cancer. 1994;30A(4):484-90.

PMID:
8018407
10.

Androgenic pathway in triple negative invasive ductal tumors: its correlation with tumor cell proliferation.

McNamara KM, Yoda T, Miki Y, Chanplakorn N, Wongwaisayawan S, Incharoen P, Kongdan Y, Wang L, Takagi K, Mayu T, Nakamura Y, Suzuki T, Nemoto N, Miyashita M, Tamaki K, Ishida T, Ohuchi N, Sasano H.

Cancer Sci. 2013 May;104(5):639-46. doi: 10.1111/cas.12121. Epub 2013 Mar 15.

PMID:
23373898
11.

Nudix-type motif 2 in human breast carcinoma: a potent prognostic factor associated with cell proliferation.

Oka K, Suzuki T, Onodera Y, Miki Y, Takagi K, Nagasaki S, Akahira J, Ishida T, Watanabe M, Hirakawa H, Ohuchi N, Sasano H.

Int J Cancer. 2011 Apr 15;128(8):1770-82. doi: 10.1002/ijc.25505.

PMID:
20533549
12.

Androgens induce divergent proliferative responses in human breast cancer cell lines.

Birrell SN, Bentel JM, Hickey TE, Ricciardelli C, Weger MA, Horsfall DJ, Tilley WD.

J Steroid Biochem Mol Biol. 1995 May;52(5):459-67.

PMID:
7748811
13.

Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma.

Jablonska K, Pula B, Zemla A, Owczarek T, Wojnar A, Rys J, Ambicka A, Podhorska-Okolow M, Ugorski M, Dziegiel P.

J Pineal Res. 2013 Apr;54(3):334-45. doi: 10.1111/jpi.12032. Epub 2013 Jan 17.

PMID:
23330677
14.

Hexokinase II in breast carcinoma: a potent prognostic factor associated with hypoxia-inducible factor-1α and Ki-67.

Sato-Tadano A, Suzuki T, Amari M, Takagi K, Miki Y, Tamaki K, Watanabe M, Ishida T, Sasano H, Ohuchi N.

Cancer Sci. 2013 Oct;104(10):1380-8. doi: 10.1111/cas.12238. Epub 2013 Aug 21.

PMID:
23869589
15.

Amyloid-β precursor protein promotes cell proliferation and motility of advanced breast cancer.

Lim S, Yoo BK, Kim HS, Gilmore HL, Lee Y, Lee HP, Kim SJ, Letterio J, Lee HG.

BMC Cancer. 2014 Dec 10;14:928. doi: 10.1186/1471-2407-14-928.

16.

Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma.

Serrero G, Hawkins DM, Yue B, Ioffe O, Bejarano P, Phillips JT, Head JF, Elliott RL, Tkaczuk KR, Godwin AK, Weaver J, Kim WE.

Breast Cancer Res. 2012 Feb 8;14(1):R26.

17.

Expression of androgen receptor in breast cancer and its significance as a prognostic factor.

Yu Q, Niu Y, Liu N, Zhang JZ, Liu TJ, Zhang RJ, Wang SL, Ding XM, Xiao XQ.

Ann Oncol. 2011 Jun;22(6):1288-94. doi: 10.1093/annonc/mdq586. Epub 2010 Nov 25.

18.

[Expression and clinical significance of LRP16 gene in human breast cancer].

Liao DX, Han WD, Zhao YL, Pu YD, Mu YM, Luo CH, Li XH.

Ai Zheng. 2006 Jul;25(7):866-70. Chinese.

PMID:
16831279
19.

Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer.

Yuan SS, Hou MF, Hsieh YC, Huang CY, Lee YC, Chen YJ, Lo S.

J Natl Cancer Inst. 2012 Oct 3;104(19):1485-502. doi: 10.1093/jnci/djs355. Epub 2012 Aug 22.

20.

Expression and prognostic role of SKIP in human breast carcinoma.

Liu X, Ni Q, Xu J, Sheng C, Wang Q, Chen J, Yang S, Wang H.

J Mol Histol. 2014 Apr;45(2):169-80. doi: 10.1007/s10735-013-9546-z. Epub 2013 Oct 23.

PMID:
24150787
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk